91062-39-4 Usage
Description
1-(BroMoMethyl)-4-propylbenzene, with the chemical formula C10H13Br and CAS number 91062-39-4, is an organic compound that features a bromine atom attached to a methyl group, which is in turn connected to a propylbenzene structure. 1-(BroMoMethyl)-4-propylbenzene is characterized by its unique molecular structure and functional groups, making it a valuable intermediate in various chemical reactions and synthesis processes.
Uses
Used in Pharmaceutical Industry:
1-(BroMoMethyl)-4-propylbenzene is used as a reagent for the preparation of heteroaryl-substituted indazoles, which are BUB1 kinase inhibitors. These inhibitors play a crucial role in the development of targeted therapies for cancer treatment, as they can help regulate cell division and prevent the uncontrolled growth of cancer cells.
Check Digit Verification of cas no
The CAS Registry Mumber 91062-39-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,0,6 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 91062-39:
(7*9)+(6*1)+(5*0)+(4*6)+(3*2)+(2*3)+(1*9)=114
114 % 10 = 4
So 91062-39-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H13Br/c1-2-3-9-4-6-10(8-11)7-5-9/h4-7H,2-3,8H2,1H3
91062-39-4Relevant articles and documents
Making a difference on excited-state chemistry by controlling free space within a nanocapsule: Photochemistry of 1-(4-alkylphenyl)-3-phenylpropan-2-ones
Sundaresan, Arun Kumar,Ramamurthy
, p. 3575 - 3578 (2008/02/12)
The free space within a reaction cavity plays a determining role during the excited-state reaction of 1-(4-alkylphenyl)-3-phenylpropan-2-ones included within a capsule formed by two molecules of a deep cavity cavitand. By controlling the free space within the reaction cavity through remote alkyl substitution on the reactant ketone it is possible to control the yield of the rearrangement product shown above.
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
-
, (2008/06/13)
Prostaglandin agonists of formula (I), in which, for example, A is a sulphonyl or acyl group, B is N or CH, M contains a ring and K and Q are linking groups, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits useful for the treatment of bone disorders including osteoporosis. STR1
